Prophylaxis and Therapy of Virulent Encephalomyocarditis Virus Infection in Mice by Monoclonal Antibodies. Brief Report
Overview
Affiliations
Two encephalomyocarditis virus (EMCV) neutralizing monoclonal antibodies (MAs), recognizing different determinants on EMCV, were both able to protect mice prophylactically and therapeutically against a lethal dose of EMCV.
c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
Buskiewicz I, Koenig A, Roberts B, Russell J, Shi C, Lee S PLoS One. 2014; 9(5):e96156.
PMID: 24816846 PMC: 4015977. DOI: 10.1371/journal.pone.0096156.
Fernandez I, Snijders A, Benaissa-Trouw B, Harmsen M, Snippe H, Kraaijeveld C J Virol. 1993; 67(10):5843-8.
PMID: 7690411 PMC: 238002. DOI: 10.1128/JVI.67.10.5843-5848.1993.
Vlaspolder F, Harmsen T, Van Veenendaal D, Kraaijeveld C, Snippe H J Clin Microbiol. 1988; 26(12):2593-7.
PMID: 2852674 PMC: 266953. DOI: 10.1128/jcm.26.12.2593-2597.1988.
Vlaspolder F, Oosterlaken T, Harmsen M, van Dijk P, Kievit H, Kraaijeveld C Arch Virol. 1990; 110(3-4):277-85.
PMID: 2156488 DOI: 10.1007/BF01311296.
Oosterlaken T, Harmsen M, Ekstijn G, Kraaijeveld C, Snippe H J Virol. 1991; 65(1):98-102.
PMID: 1845911 PMC: 240493. DOI: 10.1128/JVI.65.1.98-102.1991.